FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the month of July, 2004
Commission File Number: 1-10817
CELLTECH GROUP PLC
(Translation of registrant's name into English)
208 Bath Road, Slough, Berkshire SL1 3WE ENGLAND
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F X Form 40-F
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
(If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-________).
| Enclosure: | 1. | Additional Listing announcement dated 21 June 2004 | |||
| Enclosure: | 2. | Additional Listing announcement dated 23 June 2004 | |||
| Enclosure: | 3. | Additional Listing announcement dated 24 June 2004 | |||
| Enclosure: | 4. | Additional Listing announcement dated 25 June 2004 | |||
| Enclosure: | 5. | Additional Listing announcement dated 28 June 2004 | |||
| Enclosure: | 6. | Additional Listing announcement dated 01 July 2004 | |||
| Enclosure: | 7. | Additional Listing announcement dated 02 July 2004 | |||
| Enclosure: | 8. | Holding(s) in Company announcement dated 02 July 2004 | |||
Enclosure No. 1
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 2
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 3
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 4
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 5
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 6
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 7
Celltech Group plc.
Application has been made to The UK Listing Authority and the London Stock
Exchange for a block listing of 363,636 Ordinary shares of 50p each under the
Celltech Executive Share Option Scheme, to trade on the London Stock Exchange
and to be admitted to the Official List upon issuance. The shares shall rank
pari passu with the existing issued shares of the Company.
Copies of this announcement are available from the office of Cazenove & Co. Ltd
for the period of 2 business days from the date hereof.
Enclosure No. 8
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Celltech Group plc
2. Name of shareholder having a major interest
Credit Suisse First Boston group of companies
3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18
As in 2 above
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
| Credit Suisse First Boston Equities Limited | 13,833,917 | ||
| Credit Suisse First Boston International | 25,154 | ||
5. Number of shares / amount of stock acquired
N/a
6. Percentage of issued class
N/a
7. Number of shares / amount of stock disposed
2,431,615 (since last notification)
8. Percentage of issued class
0.87%
9. Class of security
Ordinary 50p shares
10. Date of transaction
29 June 2004
11. Date company informed
2 July 2004
12. Total holding following this notification
13,858,071
13. Total percentage holding of issued class following this notification
4.97%
14. Any additional information
15. Name of contact and telephone number for queries
Cheryl Cramer Tel: 01753 447933
16. Name and signature of authorised company official responsible for making
this notification
J A D Slater
Date of notification
2 July, 2004
The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CELLTECH
GROUP PLC
(Registrant)
By: /s/
PETER ALLEN
Peter
Allen
Chief
Financial Officer
Dated: 5 July, 2004